Patents by Inventor Christine Bjoern Jensen

Christine Bjoern Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of long-acting GLP-1 peptides
    Patent number: 10335462
    Abstract: The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: July 2, 2019
    Assignee: Novo Nordisk A/S
    Inventor: Christine Bjoern Jensen
  • Use of Long-Acting GLP-1 Peptides
    Publication number: 20180085435
    Abstract: The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc.
    Type: Application
    Filed: July 21, 2017
    Publication date: March 29, 2018
    Inventors: Christine Bjoern Jensen, Mads Frederik Rasmussen, Milan Zdravkovic, Peter Kristensen